Itoh Y - Search Results

1

PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.

Okishio S, Yamaguchi K, Ishiba H, Tochiki N, Yano K, Takahashi A, Kataoka S, Okuda K, Seko Y, Liu Y, Fujii H, Takahashi D, Ito Y, Kamon J, Umemura A, Moriguchi M, Yasui K, Okanoue T, Itoh Y. Okishio S, et al. Among authors: itoh y. Sci Rep. 2020 Nov 11;10(1):19578. doi: 10.1038/s41598-020-75805-z. Sci Rep. 2020. PMID: 33177546 Free PMC article.

2

Elevated interleukin-6 and gamma-globulin during interferon therapy of hepatitis B.

Itoh Y, Okanoue T, Enjyo F, Morimoto M, Takeuchi T, Kagawa K, Kashima K. Itoh Y, et al. Am J Gastroenterol. 1992 Oct;87(10):1485-7. Am J Gastroenterol. 1992. PMID: 1384310

3

Functional heterogeneity of rat liver macrophages: interleukin-1 secretion and Ia antigen expression in contrast with phagocytic activity.

Itoh Y, Okanoue T, Morimoto M, Nagao Y, Mori T, Hori N, Kagawa K, Kashima K. Itoh Y, et al. Liver. 1992 Feb;12(1):26-33. doi: 10.1111/j.1600-0676.1992.tb00551.x. Liver. 1992. PMID: 1564982

4

Regulation of hepatocyte albumin and alpha 1-acid glycoprotein secretion by monokines, dexamethasone, and nitric oxide synthase pathway: significance of activated liver nonparenchymal cells.

Itoh Y, Okanoue T, Enjo F, Sakamoto S, Takami S, Yasui K, Kagawa K, Kashima K. Itoh Y, et al. Dig Dis Sci. 1994 Apr;39(4):851-60. doi: 10.1007/BF02087433. Dig Dis Sci. 1994. PMID: 7512018

5

[Autoimmune disorders in interferon therapy].

Okanoue T, Itoh Y, Yasui K. Okanoue T, et al. Among authors: itoh y. Nihon Rinsho. 1994 Jul;52(7):1924-8. Nihon Rinsho. 1994. PMID: 7521440 Review. Japanese.

6

Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Yasui K, Sakamoto M, Kashima K. Itoh Y, et al. Dig Dis Sci. 1995 Nov;40(11):2423-30. doi: 10.1007/BF02063248. Dig Dis Sci. 1995. PMID: 7587825

7

Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K, Ohmoto Y. Itoh Y, et al. Am J Gastroenterol. 1995 May;90(5):777-82. Am J Gastroenterol. 1995. PMID: 7733087

8

Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease.

Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. Itoh Y, et al. J Hepatol. 1994 Oct;21(4):527-35. doi: 10.1016/s0168-8278(94)80097-9. J Hepatol. 1994. PMID: 7814798

9

Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.

Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K. Hori N, et al. Among authors: itoh y. J Gastroenterol. 1994 Aug;29(4):460-8. doi: 10.1007/BF02361244. J Gastroenterol. 1994. PMID: 7951857

10

Role of sinusoidal endothelial cells in liver disease.

Okanoue T, Mori T, Sakamoto S, Itoh Y. Okanoue T, et al. Among authors: itoh y. J Gastroenterol Hepatol. 1995;10 Suppl 1:S35-7. doi: 10.1111/j.1440-1746.1995.tb01794.x. J Gastroenterol Hepatol. 1995. PMID: 8589339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,218 results

Search Page